Abstract
PERMANENT lymphoblastoid cell lines can be established by ‘transformation’ of human lymphocytes with EB virus1,2. The lines secrete immunoglobulin (Ig) in vitro3,4 and represent, morphologically, an intermediate stage between the resting lymphocyte and the fully developed plasma cell5,6. It has been suggested that the EB virus stimulates inactive B lymphocytes to secrete immunoglobulin and that the virus is behaving, in this respect, like a polyclonal B cell mitogen. The evidence comes from observations that most (possibly all) human B lymphocytes carry surface receptors for EB virus8, that an increase in Ig secretion is detectable within a few days of adding the virus to a culture of lymphocytes7, and that in the early stages of growth, lymphoblastoid lines established in this way secrete multiple classes of Ig heavy and light chain4,9,10. It seems, however, that only a fraction of 1% of lymphocytes in an EB virus-infected culture respond either by Ig synthesis or by proliferation and furthermore that the two events occur simultaneously7,11,12. The possibility therefore remains that EB virus does not stimulate Ig synthesis de novo but selectively ‘transforms’ (that is, induces to proliferate) that minor population of B cells which has already begun to secrete Ig. This alternative is supported by our analysis of the major classes of Ig heavy and light chains secreted by lymphoblastoid cell lines (derived from peripheral blood lymphocytes) in relation to the age and clinical status of the donors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Diehl, V., Henle, G., Henle, W. & Kohn, G. in Haemic Cells In Vitro (ed. Fames, P.) 92 (Williams and Wilkins, Baltimore, 1969).
Nilsson, K., Klein, G., Henle, W. & Henle, G. Int. J. Cancer 8, 443–450 (1971).
Fahey, J. L., Finegold, I., Rabson, A. S. & Manaker, R. A. Science 152, 1259–1261 (1966).
Evans, J., Steel, C. M. & Arthur, E. Cell 3, 153–158 (1974).
De Harven, E. Cancer Res. 27, 2447–2464 (1967).
Chandra, S., Moore, G. E. & Brandt, P. M. Cancer Res. 28, 1982–1989 (1968).
Rosen, A., Gergely, P., Jondal, M., Klein, G. & Britton, S. Nature 267, 52–54 (1977).
Jondal, M. & Klein, G. J. exp. Med. 138, 1365–1378 (1978).
Bechet, J. M., Nilsson, K. & Klein, G. in Oncogenesis and Herpes Viruses (ed Briggs, P. M., de The, G. & Payne. L. M.) (Int. Agency Res. Cancer, Lyon, 249 1972).
Glade, P. R. & Papageorgiou, P. S. In Vitro 9, 202–215 (1973).
Robinson, J. & Miller, G. J. Virol 15, 1065–1072 (1972).
Thorley-Lawson, D. A., Chess, L. & Strominger, J. L. J. exp. Med. 146, 459–508 (1977).
Kearney, J. F. & Lawton, A. R. J. Immun. 115, 677–681 (1975).
Lawton, A. R., Kinkade, P. W. & Cooper, M. D. Fedn Proc. 34, 33–39 (1974).
Wu, L. Y. F., Blanco, A., Cooper, M. D. & Lawton, A. R. Clin. Immun. Immunopath. 5, 208–217 (1976).
Lawton, A. R., Self, K. S., Royal, S. A. & Cooper, M. D. Clin. Immun. Immunopath. 1, 84–93 (1972).
Janossy, G. & Greaves, M. Transplant. Rev. 24, 177–236 (1975).
Sutton, R. N. P., Reynolds, K., Almond, J. P., Marston, S. D. & Edmond, R. T. D. Clin. exp. Immun. 13, 359 (1973).
Pope, J. H. Nature 216, 810–811 (1967).
Henle, G., Henle, W. & Diehl, V. Proc. natn. Acad. Sci. U.S.A. 59, 94 (1968).
Steel, C. M. & Edmond, E. J. natn. Cancer Inst. 47, 1193–1201 (1971).
Glade, P. R., Paltrowitz, I. M. & Hirschhorn, K. Bull N.Y. Acad. Med. 45, 648–650 (1969).
Stevens, D. P., Barker, L. F., Fike, R., Hopps, H. E. & Meyer, H. M. Proc. Soc. Exp. Biol. Med. 132, 1042–1046 (1969).
Bloom, A. D., Choi, K. W. & Lamb, B. J. Science 172, 382–383 (1972).
Nilsson, K. Int. J. Cancer 8, 432–442 (1971).
Nilsson, K. Haemat. Blood Transfus. 20, 253–264 (1977).
Povey, S. et al. Ann. Hum. Genet. 36, 247–266 (1973).
Arthur, M. E. et al. Ann. Hum. Genet. 39, 33–42 (1975).
Andersson, J., Lafleur, L. & Melchers, F. Eur. J. Immun. 4, 170–180 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
STEEL, C., PHILIPSON, J., ARTHUR, E. et al. Possibility of EB virus preferentially transforming a subpopulation of human B lymphocytes. Nature 270, 729–731 (1977). https://doi.org/10.1038/270729a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/270729a0
This article is cited by
-
Chromosomal rearrangements after ex vivo Epstein–Barr virus (EBV) infection of human B cells
Oncogene (2010)
-
Identification of the human CYS1 gene and candidate gene analysis in Boichis disease
Pediatric Nephrology (2003)
-
Molecular genetic identification of families with juvenile nephronophthisis type 1: Rate of progression to renal failure
Kidney International (1997)
-
A routine method for the establishment of permanent growing lymphoblastoid cell lines
Human Genetics (1986)
-
The expression of Ia-antigen on nasopharyngeal carcinomas xenografted into nude mice
Archives of Oto-Rhino-Laryngology (1985)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.